Related Experiment Videos
Type II diabetes mellitus and menopause: a multinational study
A Monterrosa-Castro1, J E Blümel, K Portela-Buelvas
1Universidad de Cartagena , Cartagena , Colombia.
Summary
Type II diabetes mellitus is linked to early menopause, particularly in women under 45. However, menopause does not increase the risk of developing type II diabetes. This study explored risk factors and impacts on women's health.
Area of Science:
- Endocrinology
- Reproductive Health
- Metabolic Disorders
Background:
- Type II diabetes mellitus (T2DM) is associated with metabolic changes that can precipitate early menopause.
- These metabolic alterations may also exacerbate climacteric symptoms in women.
Purpose of the Study:
- To identify risk factors associated with T2DM in women.
- To evaluate the influence of T2DM on the age of menopause onset.
- To assess the impact of T2DM on the severity of climacteric symptoms.
Main Methods:
- A cross-sectional study involving 6079 women aged 40-59 from 11 Latin American countries.
- Participants completed the Menopause Rating Scale and Goldberg Anxiety-Depression Scale.
- Statistical analysis included odds ratios (OR) and 95% confidence intervals (CI) to assess associations.
Main Results:
- The prevalence of diabetes was 6.7%.
- T2DM was associated with hypertension, psychotropic drug use, hormonal therapy, age ≥ 50, overweight/obesity, and increased waist circumference.
- Lower diabetes risk was observed with hormonal contraceptive use, alcohol consumption, and residing at higher altitudes or in warmer climates.
- Diabetes significantly increased the risk of menopause before age 45 but did not worsen quality of life due to climacteric symptoms.
Conclusions:
- Menopause does not elevate the risk of developing T2DM.
- T2DM is a significant risk factor for early menopause, specifically in women under 45 years old.
Related Concept Videos
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...